These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3050344)

  • 1. Characterization of the radioiodinated analogue of SCH 23390: in vitro and in vivo D-1 dopamine receptor binding studies.
    McQuade RD; Chipkin R; Amlaiky N; Caron M; Iorio L; Barnett A
    Life Sci; 1988; 43(14):1151-60. PubMed ID: 3050344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatum.
    Billard W; Ruperto V; Crosby G; Iorio LC; Barnett A
    Life Sci; 1984 Oct; 35(18):1885-93. PubMed ID: 6387355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonergic component of SCH 23390: in vitro and in vivo binding analyses.
    McQuade RD; Ford D; Duffy RA; Chipkin RE; Iorio LC; Barnett A
    Life Sci; 1988; 43(23):1861-9. PubMed ID: 2904635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [3H]SCH 39166, a new D1-selective radioligand: in vitro and in vivo binding analyses.
    McQuade RD; Duffy RA; Anderson CC; Crosby G; Coffin VL; Chipkin RE; Barnett A
    J Neurochem; 1991 Dec; 57(6):2001-10. PubMed ID: 1834801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo binding of SCH 39166: a D-1 selective antagonist.
    McQuade RD; Duffy RA; Coffin VL; Chipkin RE; Barnett A
    J Pharmacol Exp Ther; 1991 Apr; 257(1):42-9. PubMed ID: 1826927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase.
    Makman MH; Dvorkin B
    Brain Res; 1986 Dec; 387(3):261-70. PubMed ID: 2950967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [125I]SCH 23982: the ligand of choice for identifying the D-1 dopamine receptor.
    Sidhu A; van Oene JC; Dandridge P; Kaiser C; Kebabian JW
    Eur J Pharmacol; 1986 Sep; 128(3):213-20. PubMed ID: 2947806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of D1-dopamine receptor in chicken embryo retina with [125I]SCH 23982.
    Agui T; Chase TN; Kebabian JW
    Brain Res; 1988 Jun; 452(1-2):49-56. PubMed ID: 2969765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological and behavioral effects of D1 dopamine antagonists.
    Barnett A; Iorio LC; McQuade R; Chipkin RE
    Adv Exp Med Biol; 1988; 235():137-44. PubMed ID: 2976247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology of binding of 3H-SCH-23390 to D-1 dopaminergic receptor sites in rat striatal tissue.
    Faedda G; Kula NS; Baldessarini RJ
    Biochem Pharmacol; 1989 Feb; 38(3):473-80. PubMed ID: 2563653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel affinity purification of D-1 dopamine receptors from rat striatum.
    Sidhu A
    J Biol Chem; 1990 Jun; 265(17):10065-72. PubMed ID: 2141020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine1 receptors in rat kidneys identified with 125I-Sch 23982.
    Felder RA; Jose PA
    Am J Physiol; 1988 Nov; 255(5 Pt 2):F970-6. PubMed ID: 2973247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
    Thomas KL; Rose S; Jenner P; Marsden CD
    Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct demonstration of D1 dopamine receptors in the bovine parathyroid gland using the D1 selective antagonist [125I]-SCH 23982.
    Monsma FJ; Sibley DR
    Synapse; 1989; 3(3):193-9. PubMed ID: 2524116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Striatal D1- and D2-dopamine receptor sites are separately detectable in vivo.
    Leslie CA; Bennett JP
    Brain Res; 1987 Jul; 415(1):90-7. PubMed ID: 2957025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of 125I-SCH 23982 and [3H]SCH 23390 as ligands for the D-1 dopamine receptor.
    Manik CP; Molinoff PB; McGonigle P
    J Neurochem; 1988 Aug; 51(2):391-7. PubMed ID: 3292702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for different states of the dopamine D1 receptor: clozapine and fluperlapine may preferentially label an adenylate cyclase-coupled state of the D1 receptor.
    Andersen PH; Braestrup C
    J Neurochem; 1986 Dec; 47(6):1822-31. PubMed ID: 2945903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective blockade of dopamine D-1 receptors by SCH 23390 discloses striatal dopamine D-2 receptors mediating the inhibition of adenylate cyclase in rats.
    Onali P; Olianas MC; Gessa GL
    Eur J Pharmacol; 1984 Mar; 99(1):127-8. PubMed ID: 6233165
    [No Abstract]   [Full Text] [Related]  

  • 19. Solubilization of the D-1 dopamine receptor from rat striatum.
    Sidhu A; Fishman PH
    Biochem Biophys Res Commun; 1986 Jun; 137(3):943-9. PubMed ID: 3729958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of agonist and antagonist binding to striatal D-1 dopamine receptors: studies using the selective D-1 antagonist [3H]SK&F R-83566.
    Flaim KE; Gessner GW; Crooke ST; Heys JR; Weinstock J
    Life Sci; 1986 Jun; 38(23):2087-96. PubMed ID: 2872567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.